Ibis Therapeutics

Q: What is Ibis Therapeutics's official website?

Ibis Therapeutics's official website is www.ibistx.com

Q: What is Ibis Therapeutics's Revenue?

Ibis Therapeutics's revenue is <$5 Million

Q: What is Ibis Therapeutics's SIC code?

Ibis Therapeutics's SIC: 87,873

Q: What is Ibis Therapeutics's NAICS code?

Ibis Therapeutics's NAICS: 54,541

Q: How many employees does Ibis Therapeutics have?

Ibis Therapeutics has 11-50 employees

Q: What industry does Ibis Therapeutics belong to?

Ibis Therapeutics is in the industry of: Business Services , Research & Development

Q: What technology does Ibis Therapeutics use?

Some of the popular technologies that Ibis Therapeutics uses are: Sentry, F5 BIG-IP Platform, F5 BIG-IP Application Security Manager, Wix

Q: What does Ibis Therapeutics do?

Ibis Therapeutics specializes in accelerating drug discovery through its innovative Molecular Fingerprint Platform. This AI-based platform offers integrated solutions for novel drug discovery, selectivity and safety assessment, and polypharmacology prediction. The company targets a wide range of off-targets and co-targets in the human genome to enh... ance on-target efficacy while minimizing off-target toxicity. Ibis Therapeutics collaborates on research projects and out-licenses drug-target-disease combinations for drug repurposing and novel preclinical assets. Read More

Q: Is Ibis Therapeutics a public company?

Ibis Therapeutics is private company therefore does not currently have an official ticker symbol

Business Services · Florida, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

3802 Spectrum Blvd Ste 146, Tampa, Flori...

Website

www.ibistx.com

Revenue

<$5 Million

Industry

Business Services

Research & Development

ZI Rank: 1

Signal Type

Jan

Feb

Mar

Apr

May

Jun

ZI Rank

About Ibis Therapeutics

Ibis Therapeutics specializes in accelerating drug discovery through its innovative Molecular Fingerprint Platform. This AI-based platform offers integrated solutions for novel drug discovery, selectivity and safety assessment, and polypharmacology prediction. The company targets a wide range of off-targets and co-targets in the human genome to enhance on-target efficacy while minimizing off-target toxicity. Ibis Therapeutics collaborates on research projects and out-licenses drug-target-disease combinations for drug repurposing and novel preclinical assets.Explore more

Is this data correct?

Popular SearchesIbis TherapeuticsSIC Code 87,873NAICS Code 54,541Show more

Is Ibis Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Last 7 days

Click to see if Ibis Therapeutics had a recent Job posting/layoffs

Website visits: Recent activity has been detected on your website

Congratulate Masked Content for being promoted to Masked Content at Ibis Therapeutics

Funding: Get notified immidiatlly once Ibis Therapeutics has new funding data

Check out if Ibis Therapeutics is spiking on competitors!

Ibis Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic

Check if Ibis Therapeutics has recently received funding, and reach out quickly before it becomes old news!

Competitive Alert! Recent activity has been detected by your competitor Masked Content

Earning: See what the market has to say on Ibis Therapeutics recently announced quarterly report

Product Launch: Get notified when Ibis Therapeutics launches new products

Recommended Actions

Reach out to Masked Content who joined Ibis Therapeutics as Masked Content

Find 2 more new buyers

View Email Formats for Ibis Therapeutics